English
- English
- 中文
-
News Center
-
News Center
-
Pamedic Spotlight｜The Overview of 2024 Q1 Financing for Nuclear Drug
In the first quarter of 2024, the investment and acquisition boom in the nuclear
View Details -
Pamedic Spotlight｜Voices of the Two Sessions——Scientific, Safe and Efficient Development of the Nuclear Drugs Industry
During the Two Sessions of the National People's Congress, a series of important
View Details -
Pamedic Spotlight｜Nuclear Drugs, China Poised for Take-off
Nuclear drugs, also called radiopharmaceuticals and nuclide drugs, are pharmaceu
View Details -
Pamedic Spotlight｜Global Layout of RDC Racetrack
In recent years, the field of nuclear drugs (radiotherapy) has attracted a lot o
View Details -
Pamedic Spotlight｜Radionuclide Drug Conjugates (RDC): a New Era in Targeted Tumour Therapy
In recent years, Radionuclide-adionuclide Drug Conjugates (RDC) have emerged in
View Details -
Pamedic Spotlight｜Dynamics of Radiopharmaceuticals Business
Recently, a number of notable progress have been made in radiopharmaceuticals b
View Details -
Pamedic Spotlight｜Interpretation of the Technical Guidelines for Non-clinical Studies of Therapeutic Radiopharmaceuticals
On 22.1.2024, Center For Drug Evaluation issued the Technical Guidelines for Non
View Details -
Pamedic Spotlight｜Performance Comparison between α-isotopes and β-isotopes
As medical science and technology develops, radioisotope therapy has become an i
View Details
Email: pchl@pamedicholdings.com
Address: Room 406, Building C, Hetao Innovation Center No. 1 Honghua
Road, Fubao Subdistrict Futian District, Shenzhen, China
Copyright@2025 PanMediso
